Literature DB >> 25207146

Prevalence of chronic obstructive pulmonary disease in kocaeli: an industrialised city in Turkey.

Zeliha Arslan1, Ahmet Ilgazlı1, Nilay Etiler2, Onur Hamzaoğlu2.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an important cause of mortality worldwide. AIMS: The aim of this study was to establish the prevalence of chronic obstructive pulmonary disease (COPD) in residents who were ≥40 years old and living in a heavily industrialised city of Turkey, Kocaeli, using the Burden of Obstructive Lung Disease Initiative questionnaire. STUDY
DESIGN: Cross-sectional study.
METHODS: 1035 residents ≥40 years old and living in Kocaeli were surveyed. Spirometry and the basic BOLD questionnaire was performed.
RESULTS: 946 subjects entered into the analysis. The prevalence of stage I or higher COPD was 13.3% (8.7% for women and 16.5% for men), the prevalence of COPD at GOLD stage II or higher was 7.1% (4.1% for women and 9.2% for men). We also noted a high prevalence of COPD in never-smokers.
CONCLUSION: Besides cigarette smoking, occupational exposure to fumes, chemicals and dusts might have also contributed to the high prevalence of COPD noted in residents who were ≥40 years old and living in Kocaeli, Turkey.

Entities:  

Keywords:  COPD; age; cigarette smoking; epidemiology; prevalence; questionnaires

Year:  2013        PMID: 25207146      PMCID: PMC4115957          DOI: 10.5152/balkanmedj.2013.8042

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  22 in total

1.  The occupational burden of chronic obstructive pulmonary disease.

Authors:  L Trupin; G Earnest; M San Pedro; J R Balmes; M D Eisner; E Yelin; P P Katz; P D Blanc
Journal:  Eur Respir J       Date:  2003-09       Impact factor: 16.671

2.  Interpreting COPD prevalence estimates: what is the true burden of disease?

Authors:  R J Halbert; Sharon Isonaka; Dorothy George; Ahmar Iqbal
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

Review 3.  The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design.

Authors:  A Sonia Buist; William M Vollmer; Sean D Sullivan; Kevin B Weiss; Todd A Lee; Ana M B Menezes; Robert O Crapo; Robert L Jensen; Peter G J Burney
Journal:  COPD       Date:  2005-06       Impact factor: 2.409

4.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

7.  Gender differences in health: results from SHARE, ELSA and HRS.

Authors:  Eileen M Crimmins; Jung Ki Kim; Aïda Solé-Auró
Journal:  Eur J Public Health       Date:  2010-03-17       Impact factor: 3.367

8.  The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands.

Authors:  T L Feenstra; M L van Genugten; R T Hoogenveen; E F Wouters; M P Rutten-van Mölken
Journal:  Am J Respir Crit Care Med       Date:  2001-08-15       Impact factor: 21.405

9.  Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study.

Authors:  Ana Maria B Menezes; Rogelio Perez-Padilla; José Roberto B Jardim; Adriana Muiño; Maria Victorina Lopez; Gonzalo Valdivia; Maria Montes de Oca; Carlos Talamo; Pedro C Hallal; Cesar G Victora
Journal:  Lancet       Date:  2005-11-26       Impact factor: 79.321

10.  Chronic obstructive pulmonary disease (COPD) and occupational exposures.

Authors:  Piera Boschetto; Sonia Quintavalle; Deborah Miotto; Natalina Lo Cascio; Elena Zeni; Cristina E Mapp
Journal:  J Occup Med Toxicol       Date:  2006-06-07       Impact factor: 2.646

View more
  6 in total

1.  Does Nutritional Risk Screening 2002 Correlate with the Dyspnea Status of Patients with GOLD Stage C-D Chronic Obstructive Pulmonary Disease?

Authors:  Nalan Ogan; Fatma Yıldırım; Banu Süzen; Ayşe Baha; Evrim Eylem Akpınar
Journal:  Turk Thorac J       Date:  2020-01-01

2.  Evaluation of malnutrition detected with the Nutritional Risk Screening 2002 (NRS-2002) and the quality of life in hospitalized patients with chronic obstructive pulmonary disease.

Authors:  M Arslan; M Soylu; G Kaner; N İnanç; E Başmısırlı
Journal:  Hippokratia       Date:  2016 Apr-Jun       Impact factor: 0.471

3.  Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique.

Authors:  Ignacio Blanco; Isidro Diego; Patricia Bueno; Eloy Fernández; Francisco Casas-Maldonado; Cristina Esquinas; Joan B Soriano; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-21

4.  Thyroid Gland Disease as a Comorbid Condition in COPD.

Authors:  Aziz Gumus; Neslihan Ozcelik; Bilge Yilmaz Kara; Songul Ozyurt; Unal Sahin
Journal:  Pulm Med       Date:  2021-10-29

5.  The CO-MIND Study: Chronic Obstructive Pulmonary Disease Management in Daily Practice and Its Implications for Improved Outcomes According to GOLD 2019 Perspective.

Authors:  Hakan Gunen; Nurdan Kokturk; Sibel Naycı; Sevket Ozkaya; Birsen Pınar Yıldız; Onur Turan; Aziz Gumus; Metin Akgun; Alev Gurgun; Candan Ogus; Arzu Mirici; Elif Sen; Nazan Bayram; Volkan Eken; Hakan Erkus
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-08-18

Review 6.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.